Cardiotoxicity in haematological diseases: are the tyrosine kinase inhibitors imatinib and nilotinib safe?
EUROPEAN HEART JOURNAL(2017)
摘要
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017.
更多查看译文
关键词
tyrosine kinase inhibitors imatinib,haematological diseases,nilotinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要